Summary
Four of the six largest products in our category will not tell you what they cost. A survey of 121 AI scribe products found 42 percent would not disclose anything without a demo first.3
We publish on one page. Not as a favour. Because the alternative is a business model we do not want.
One page, one price, the same for everyone. No demo required to see it.
Book a demoWhere the category is
Heidi publishes $150. Freed publishes $39 to $119. Abridge, Nabla, Suki and DAX Copilot do not publish.44Published pricing as at July 2026, Heidi and Freed. Unpublished, Abridge, Nabla, Suki and DAX Copilot. Suki is reported to carry a $500 to $2,000 setup fee and a one-year minimum. DAX Copilot is typically sold through a Microsoft reseller against an existing licence position. Two out of six.
DAX is sold through a Microsoft reseller against your existing licence position, so the number depends on what else you buy from Microsoft. Two practices pay differently for identical software. An unpublished price exists to make that possible rather than to hide a spreadsheet.
What the call is actually for
Discovery. Which means finding out how much you can pay before quoting you. A published price cannot do that, and the discovery call exists precisely because it cannot.
It also costs you a week. You wanted to compare four products on a Tuesday afternoon and instead you have four calendar invitations and a sales cycle.
What it costs us to publish
Real money. We cannot charge a health system more than a four-doctor practice for the same product, and health systems will pay more. Every competitor who does not publish is capturing that and we are not.
We also lose the deals where the number is genuinely too high, without ever getting the chance to talk you round. Those are real losses and we take them.
Why we do it anyway
Because the alternative is a company whose commercial advantage comes from you not knowing something. Once that works, it works everywhere, and the next thing we would keep from you is the retention window or the trial terms.
Publishing is a constraint we put on ourselves to stop that being available.
What else should be published
One number stays unpublished across this entire category. Whether any of it works financially. From 2026 your E/M level turns on Medical Decision Making and the note is the evidence for the code.55From 2026, Medical Decision Making is the primary basis for E/M level selection. AAPC reports up to 19 percent of E/M visits undercoded at roughly $37 each. Reported MA downcoding runs $42 to $74 per visit. Up to 19 percent of E/M visits are undercoded at roughly $37 each.
No vendor publishes a submitted-versus-paid E/M variance figure, ourselves included. Our prices are public and our outcome data is not, and we would rather name that than let the pricing page stand in for it.
What we are not claiming
Publishing a price is not a virtue, it is a choice with a cost we have decided to pay. Heidi and Freed do it too and we are not special for it.
Abridge not publishing is also defensible. Enterprise deals are genuinely bespoke and a single number would mislead. We disagree with the conclusion rather than the reasoning.
Availability
Our prices are on one page, the same for everyone, no setup fee and no minimum term.
Frequently asked questions
Which AI medical scribes publish their pricing?
Two of the six largest. Heidi publishes $150 per user per month billed annually with a free tier at ten actions. Freed publishes $39 for 40 notes, $79 unlimited and $119 with letters and coding. Abridge, Nabla, Suki and DAX Copilot do not. A survey of 121 AI scribe products found 42 percent required direct vendor contact or a demonstration before disclosing anything at all.
Why do software companies hide their pricing?
Discovery, which means finding out how much you can pay before quoting you. A published price cannot do that, and the call exists precisely because it cannot. DAX Copilot is sold through a Microsoft reseller against your existing licence position, so the number depends on what else you buy from Microsoft and two practices pay differently for identical software. It also costs you a week. You wanted to compare four products on a Tuesday and instead you have four calendar invitations.
Is there anything AI scribe vendors should publish and do not?
Whether any of it works financially. From 2026 E/M level selection turns on Medical Decision Making, so the note is the evidence for the code, and up to 19 percent of E/M visits are undercoded at roughly $37 each. No vendor in this category publishes a submitted-versus-paid E/M variance figure, ourselves included. Our prices are public and our outcome data is not, and we would rather name that than let the pricing page stand in for it.
See the number first. Then decide if we are worth a call.
Thirty minutes, your own workflow, running live. The price is already on the site.
About this article. Written and published by WA\, which publishes its pricing and is therefore arguing its own book. The 121-product survey is independent research. Competitor pricing practices are from public sources current at the updated date above. WA\ does not publish outcome data and has said so above. All names are marks belonging to their owners.